Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FADS1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | KLF2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | PARP15 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SQLE | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SHF | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | RABIF | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | TAF13 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | ANKRD22 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | HIST2H4A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | INTS3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |